Moderna Funding & Investors
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
https://www.modernatx.com/Total Amount Raised: $2,981,600,256
Moderna Funding Rounds
Grant
$483,000,000
Grant Investors
Biomedical Advanced Research and Development Authority (BARDA)Series H
$125,000,000
Series H Investors
MerckSeries G
$500,000,000
Series G Investors
Abu Dhabi Investment AuthoritySequoia ChinaJulius Baer GroupAlexandria Venture InvestmentsViking Global InvestorsBB Biotech VenturesArrowMark PartnersPictet GroupFidelity InvestmentsEDBIGrant
$8,000,000
Grant Investors
Biomedical Advanced Research and Development Authority (BARDA)Series F
$474,000,000
Series F Investors
AstraZenecaGrant
$20,000,000
Grant Investors
Bill & Melinda Gates FoundationSeries E
$450,000,000
Series E Investors
Ra Capital ManagementViking Global InvestorsWellington ManagementInvusAstraZenecaAlexion PharmaceuticalsCorporate Round
$25,000,000
Corporate Round Investors
Alexion PharmaceuticalsPost Ipo Equity
$250,000,000
Post Ipo Equity Investors
MSD CapitalGrant
$472,000,000
Grant Investors
Biomedical Advanced Research and Development Authority (BARDA)Post Ipo Equity
$250,000,000
Post Ipo Equity Investors
MSD CapitalGrant
$472,000,000
Grant Investors
Biomedical Advanced Research and Development Authority (BARDA)Series Unknown
$110,000,000
Series Unknown Investors
Flagship PioneeringGrant
$24,600,000
Grant Investors
Defense Advanced Research Projects Agency (DARPA)Series Unknown
$40,000,000
Series Unknown Investors
Flagship Pioneering
Funding info provided by Diffbot.